Antimicrobial aptamers for detection and inhibition of microbial pathogen growth

被引:3
作者
Ozalp, Veli Cengiz [1 ,2 ]
Bilecen, Kivanc [1 ]
Kavruk, Murat [1 ,2 ]
Oktem, Huseyin Avni [1 ,2 ]
机构
[1] Nanobiz Ltd, MetuTechnopolis, TR-06800 Ankara, Turkey
[2] Middle E Tech Univ, Dept Biol Sci, TR-06800 Ankara, Turkey
关键词
antibiotics; antimicrobial agents; aptamers; biosensors; hygiene monitoring; multidrug resistance; pathogens; riboswitches; IMMUNODEFICIENCY-VIRUS TYPE-1; VIRAL NUCLEOPROTEIN BINDING; IN-VITRO SELECTION; DNA APTAMERS; RNA APTAMERS; SALMONELLA-TYPHIMURIUM; REVERSE-TRANSCRIPTASE; SYSTEMATIC EVOLUTION; SSDNA APTAMERS; EMERGING CLASS;
D O I
10.2217/FMB.12.149
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Discovery of alternative sources of antimicrobial agents are essential in the ongoing battle against microbial pathogens. Legislative and scientific challenges considerably hinder the discovery and use of new antimicrobial drugs, and new approaches are in urgent demand. On the other hand, rapid, specific and sensitive detection of airborne pathogens is becoming increasingly critical for public health. In this respect affinity oligonucleotides, aptamers, provide unique opportunities for the development of nanotechnological solutions for such medical applications. In recent years, aptamers specifically recognizing microbial cells and viruses showed great potential in a range of analytical and therapeutic applications. This article describes the significant advances in the development of aptamers targeting specific pathogens. Therapeutic application of aptamers as neutralizing agents demonstrates great potential as a future source of antimicrobial agent.
引用
收藏
页码:387 / 401
页数:15
相关论文
共 115 条
[1]   Evaluation of ATP Bioluminescence Assays for Potential Use in a Hospital Setting [J].
Aiken, Zoie A. ;
Wilson, Michael ;
Pratten, Jonathan .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2011, 32 (05) :507-509
[2]   Use of miniaturized protein arrays for Escherichia coli O serotyping [J].
Anjum, Muna F. ;
Tucker, James D. ;
Sprigings, Katherine A. ;
Woodward, Martin J. ;
Ehricht, Ralf .
CLINICAL AND VACCINE IMMUNOLOGY, 2006, 13 (05) :561-567
[3]  
Barbas AS, 2010, FUTURE ONCOL, V6, P1117, DOI [10.2217/fon.10.67, 10.2217/FON.10.67]
[4]   Sequencing emm-specific PCR products for routine and accurate typing of group a streptococci [J].
Beall, B ;
Facklam, R ;
Thompson, T .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) :953-958
[5]   Isolation of peptide aptamers that inhibit intracellular processes [J].
Blum, JH ;
Dove, SL ;
Hochschild, A ;
Mekalanos, JJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (05) :2241-2246
[6]   In vivo biodistribution and pharmacokinetics of 18F-labelled Spiegelmers:: a new class of oligonucleotidic radiopharmaceuticals [J].
Boisgard, R ;
Kuhnast, B ;
Vonhoff, S ;
Younes, C ;
Hinnen, F ;
Verbavatz, JM ;
Rousseau, B ;
Fürste, J ;
Wlotzka, B ;
Dollé, F ;
Klussmann, S ;
Tavitian, B .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (04) :470-477
[7]   Quantification of Receptor Targeting Aptamer Binding Characteristics Using Single-Molecule Spectroscopy [J].
Book, Brittany ;
Chen, Jiji ;
Irudayaraj, Joseph .
BIOTECHNOLOGY AND BIOENGINEERING, 2011, 108 (05) :1222-1227
[8]   Discovery and Development of Therapeutic Aptamers [J].
Bouchard, P. R. ;
Hutabarat, R. M. ;
Thompson, K. M. .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2010, 50 :237-257
[9]  
Breaker RR, 2009, FUTURE MICROBIOL, V4, P771, DOI [10.2217/fmb.09.46, 10.2217/FMB.09.46]
[10]   Salmonella nomenclature - Guest commentary [J].
Brenner, FW ;
Villar, RG ;
Angulo, FJ ;
Tauxe, R ;
Swaminathan, B .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (07) :2465-2467